How should rituximab be tapered in patients with neurosarcoidosis who are in remission?

How would you taper Rituximab in patients with neurosarcoidosis who are in remission?

• Extend the dosing interval (from every 6 months to 8-12 months or longer)
• Reduce the dose while maintaining the same interval
• Stop rituximab after a defined period of remission
• Continue rituximab without tapering due to relapse concerns
• Individualize tapering based on clinical factors such as disease severity, prior relapses, MRI findings, etc
• Other